News | September 02, 2021
Sun Pharma Industries announce sale of Kayaku
The company has been sold to Shinshin Pharmaceuticals
The company has been sold to Shinshin Pharmaceuticals
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices
Invega Hafyera offers patients the fewest doses per year. Phase 3 non-inferiority study results showed over 92% of participants were relapse-free at 12 months
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya
The powder is approved for the treatment of adjunct therapy in moderate to severe Covid-19 patients
PPH is associated with almost 20 per cent of maternal mortality in India
Subscribe To Our Newsletter & Stay Updated
